United States · 
Who invested in Adoram Therapeutics?
Adoram Therapeutics's investors include Innosuisse.
United States · Funded startup
Who invested in Adoram Therapeutics
Funding summaryUpdated 26 Oct 2026
$1.3Mraised across 1 round since 2025, from 1 source
- Latest round
- Grant, $1.3MMay 2025
- Investors
- 1
The rounds
- May 2025
Founders and team
From Adoram Therapeutics's own website: 2 founders.
David PejoskiCo-founder & CEO
Hesham HamedCo-Founder & CSO
AdvisersLeonardo Scapozza
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Adoram Therapeutics
How much has Adoram Therapeutics raised?
Adoram Therapeutics has raised $1.3M across 1 round since 2025.
When did Adoram Therapeutics last raise?
Adoram Therapeutics's most recent round was a Grant of $1.3M in May 2025.
What was Adoram Therapeutics's biggest round?
Its most recent round, $1.3M in May 2025, is also its largest on record.
Who backed Adoram Therapeutics first?
Adoram Therapeutics's first round on record, in May 2025, was backed by Innosuisse.
What stage is Adoram Therapeutics at?
Adoram Therapeutics's latest named round is a Grant, in May 2025.
Where is Adoram Therapeutics based?
Adoram Therapeutics is based in the United States.
Companies like Adoram Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.